Gentian Diagnostics
Less than 1K followers
GENT
Oslo Børs
Medical Equipment & Services
Health Care
Overview
Investor consensus
Gentian Diagnostics is a medical diagnostics company that develops and manufactures in vitro diagnostic reagents for high-throughput analyzers. Gentian's expertise and focus lies in homogeneous immunoassays, specifically infections, inflammation, renal failure and congestive heart failure. The company's headquarters and production facilities are located in Moss, Norway, and serves the global human and veterinary diagnostics market through sales and representative offices in a number of key countries.
Read moreMarket cap
-
Turnover
-
Revenue
176.5M
EBIT %
14.42 %
P/E
-
Dividend yield-%
-
Financial calendar
5/5
2026
General meeting '26
6/5
2026
Interim report Q1'26
6/5
2026
Annual dividend
All
Press releases
ShowingAll content types
GENT: Mandatory notification of trade
GENT: Mandatory notification of trade
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools